Near-infrared spectroscopic tissue imaging for medical applications
View Patent ↗Near infrared imaging using elastic light scattering and tissue autofluorescence are explored for medical applications. The approach involves imaging using cross-polarized elastic light scattering and tissue autofluorescence in the Near Infra-Red (NIR) coupled with image processing and inter-image operations to differentiate human tissue components.
1. A diagnostic method, comprising:
interrogating one or more tissue components with a directed electromagnetic radiation source having one or more substantially narrow predetermined wavelengths,
detecting a scattered electromagnetic radiation and a near infrared autofluorescence emission having one or more wavelengths and polarization states from said tissue components; and
characterizing said tissue components by performing inter-image operations on said detected scattered radiation and said near infrared autofluorescence emission to enhance image contrast and visibility of said tissue components in a specimen.
2. The method of claim 1 , wherein said detecting step includes a device selected from a liquid nitrogen cooled CCD camera, a two-dimensional array detector, an avalanche CCD photodetector, a photomultiplier and a photodiode capable of point by point scanning.
3. The method of claim 1 , wherein said detecting step includes collection of a near-infrared autofluorescence emission having a predetermined spectral band generated by said tissue components after illumination by said source.
4. The method of claim 3 , wherein said near infrared autofluorescence emission further comprises electromagnetic radiation in the near-infra red spectral region between about 600 nm and about 1500 nm.
5. The method of claim 3 , wherein said electromagnetic radiation source is polarized and said near-infrared autofluorescence emission is analyzed.
6. The method of claim 5 , wherein said electromagnetic radiation source is linearly polarized and a parallel-polarized component of said near-infrared autofluorescence emission is analyzed.
7. The method of claim 5 , wherein said electromagnetic source is linearly polarized and a perpendicularly polarized component of said near-infrared autofluorescence emission is analyzed.
8. The method of claim 5 , wherein said electromagnetic source is circularly polarized and a same circular polarization orientation of said near-infrared autofluorescence emission is analyzed.
9. The method of claim 8 , wherein said near-infrared autofluorescence emission having an opposite circular polarization orientation with respect to said electromagnetic radiation source is analyzed.
10. The method of claim 5 , wherein said electromagnetic source is elliptically polarized and a same elliptical polarization orientation of said near-infrared autofluorescence emission is analyzed.
11. The method of claim 10 , wherein an orthogonal elliptical polarization of said near-infrared autofluorescence emission is analyzed.
12. The method of claim 1 , wherein said electromagnetic source is polarized and said scattered electromagnetic radiation is analyzed.
13. The method of claim 12 , wherein said electromagnetic source is polarized and an orthogonal polarization component of said scattered electromagnetic radiation is analyzed.
14. The method of claim 12 , wherein said polarized electromagnetic source is selected from, linear, circular or elliptical polarization.
15. The method of claim 12 , wherein said scattered electromagnetic radiation is in the near infra-red between about 600 nm and about 1500 nm.
16. The method of claim 1 , wherein a plurality of real time images produced from said tissue components are visualized by a device.
17. The method of claim 16 , wherein said characterizing step comprises the further step of image processing said plurality of real time images by a device.
18. The method of claim 17 , wherein one or more inter-image operations are performed by said device on said images, wherein said device is a computer having image processing software and one or more display means.
19. The method of claim 1 , wherein said detected scattered radiation having a cross-polarized component with respect to said electromagnetic radiation source is analyzed.
20. The method of claim 1 , wherein one or more predetermined illumination spectral bands is selected from said electromagnetic radiation and inter-image operations are performed by a device on a detected scattered radiation produced from said illumination spectral bands to enhance image contrast and visibility of said tissue components in a specimen.
21. The method of claim 20 , wherein a cross-polarized component of said detected scattered radiation with respect to said electromagnetic source from said scattered one or more spectral bands is analyzed.
22. The method of claim 18 , wherein said inter-image operations are selected between at least two images from a near-infrared cross-polarized light scattering image of a first wavelength, a near-infrared cross-polarized light scattering image of a first spectral band, a near-infrared cross-polarized light scattering image of a second wavelength, a near-infrared cross-polarized light scattering image of a second spectral band, a near-infrared parallel-polarized light scattering image of a first wavelength, a near-infrared parallel-polarized light scattering image of a second wavelength, a near-infrared parallel-polarized light scattering image of a first spectral band, a near-infrared parallel-polarized light scattering image of a second spectral band, a near-infra-red Autofluorescence image under a first excitation wavelength, a near-infra-red Autofluorescence image under a second excitation wavelength, a near-infra-red Autofluorescence image in a first emission spectral band, a near-infra-red Autofluorescence image in a second emission spectral band, an orthogonal-polarization component of said near-infrared Autofluorescence image produced by a polarized excitation, and a parallel-polarization component of said near-infrared Autofluorescence image produced by said polarized excitation to enhance image contrast and visibility of one or more human tissue components.
23. The method of claim 1 , wherein said method is used to image and differentiate malignant tumors from benign tumors and normal tissue.
24. The method of claim 1 , wherein said method is used to enhance image visibility and tissue component contrast.
25. The method of claim 1 , wherein said source comprises electromagnetic radiation having a wavelength of at least 500 nm.
26. The method of claim 1 , wherein said tissue components comprise human tissue.
27. The method of claim 26 , wherein said tissue components are selected from normal, abnormal, organs, vascular, and nerve tissue components.